{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:20:03Z","timestamp":1791181203624,"version":"4.1.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Trypanosomiasis remains a significant disease across the sub-Saharan African continent, with 50,000 to 70,000 individuals infected. The utility of current therapies is limited by issues of toxicity and the need to administer compounds intravenously. We have begun a program to pursue lead optimization around MDL 73811, an irreversible inhibitor of<jats:italic>S<\/jats:italic>-adenosylmethionine decarboxylase (AdoMetDC). This compound is potent but in previous studies cleared rapidly from the blood of rats (T. L. Byers, T. L. Bush, P. P. McCann, and A. J. Bitonti, Biochem. J. 274:527-533). One of the analogs synthesized (Genz-644131) was shown to be highly active against<jats:italic>Trypanosoma brucei rhodesiense<\/jats:italic>in vitro (50% inhibitory concentration, 400 pg\/ml). Enzyme kinetic studies showed Genz-644131 to be approximately fivefold more potent than MDL 73811 against the<jats:italic>T. brucei brucei<\/jats:italic>AdoMetDC-prozyme complex. This compound was stable in vitro in rat and human liver microsomal and hepatocyte assays, was stable in rat whole-blood assays, did not significantly inhibit human cytochrome P450 enzymes, had no measurable efflux in CaCo-2 cells, and was only 41% bound by serum proteins. Pharmacokinetic studies of mice following intraperitoneal dosing showed that the half-life of Genz-644131 was threefold greater than that of MDL 73811 (7.4 h versus 2.5 h). Furthermore, brain penetration of Genz-644131 was 4.3-fold higher than that of MDL 73811. Finally, in vivo efficacy studies of<jats:italic>T. b. brucei<\/jats:italic>strain STIB 795-infected mice showed that Genz-644131 significantly extended survival (from 6.75 days for controls to &gt;30 days for treated animals) and cured animals infected with<jats:italic>T. b. brucei<\/jats:italic>strain LAB 110 EATRO. Taken together, the data strengthen validation of AdoMetDC as an important parasite target, and these studies have shown that analogs of MDL 73811 can be synthesized with improved potency and brain penetration.<\/jats:p>","DOI":"10.1128\/aac.01674-08","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T00:54:09Z","timestamp":1237251249000},"page":"2052-2058","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":40,"title":["Novel<i>S<\/i>-Adenosylmethionine Decarboxylase Inhibitors for the Treatment of Human African Trypanosomiasis"],"prefix":"10.1128","volume":"53","author":[{"suffix":"Jr.","given":"Robert H.","family":"Barker","sequence":"first","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlan","family":"Liu","sequence":"additional","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford","family":"Hirth","sequence":"additional","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra A.","family":"Celatka","sequence":"additional","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fitzpatrick","sequence":"additional","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Xiang","sequence":"additional","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Willert","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390-9041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390-9041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Swiss Tropical Institute, Parasite Chemotherapy, Socinstrasse 57, P.O. Box CH-4002, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus J.","family":"Bacchi","sequence":"additional","affiliation":[{"name":"Haskins Laboratory"},{"name":"Department of Biological and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixa","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Haskins Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Yarlett","sequence":"additional","affiliation":[{"name":"Haskins Laboratory"},{"name":"Department of Chemistry and Physical Sciences, Pace University, 41 Park Row, New York, New York 10038"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Klinger","sequence":"additional","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Sybertz","sequence":"additional","affiliation":[{"name":"Genzyme Corporation, 153 Second Avenue, Waltham, Massachusetts 02451"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"365","volume":"22","year":"2004","unstructured":"Avdeef, A., P. E. Nielsen, and O. Tsinman. 2004. PAMPA: a drug absorption in vitro model. 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates. Eur. J. Pharm. Sci.22:365-374.","journal-title":"Eur. J. Pharm. Sci."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1550-7408.1981.tb02798.x","volume":"28","year":"1981","unstructured":"Bacchi, C. J. 1981. Content, synthesis, and function of polyamines in trypanosomatids: relationship to chemotherapy. J. Protozool.28:20-27.","journal-title":"J. Protozool."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1448"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.131.2.657-661.1977"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6775372"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.12.2736"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1021\/bi0603975","volume":"45","year":"2006","unstructured":"Beswick, T. C., E. K. Willert, and M. A. Phillips. 2006. Mechanisms of allosteric regulation of Trypanosoma cruzi S-adenosylmethionine decarboxylase. Biochemistry45:7797-7807.","journal-title":"Biochemistry"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.8.1485"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01948.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-002-0766-5"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/bj2740527","volume":"274","year":"1991","unstructured":"Byers, T. L., T. L. Bush, P. P. McCann, and A. J. Bitonti. 1991. Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-l-methionine. Biochem. J.274:527-533.","journal-title":"Biochem. J."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj2830755","volume":"283","year":"1992","unstructured":"Byers, T. L., P. Casara, and A. J. Bitonti. 1992. Uptake of the antitrypanosomal drug 5\u2032-([(Z)-4-amino-2-butenyl]methylamino)-5\u2032-deoxyadenosine (MDL 73811) by the purine transport system of Trypanosoma brucei brucei. Biochem. J.283:755-758.","journal-title":"Biochem. J."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja00207a024"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1978.tb03887.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/abio.1997.2145","volume":"248","year":"1997","unstructured":"Crespi, C. L., V. P. Miller, and B. W. Penman. 1997. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem.248:188-190.","journal-title":"Anal. Biochem."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-002-0752-y"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2003.09.002"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0006-2952(00)00560-8","volume":"61","year":"2001","unstructured":"Goldberg, B., D. Rattendi, D. Lloyd, J. R. Sufrin, and C. J. Bacchi. 2001. In situ kinetic characterization of methylthioadenosine transport by the adenosine transporter (P2) of the African Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Biochem. Pharmacol.61:449-457.","journal-title":"Biochem. Pharmacol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0310415"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200412000-00009"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","volume":"41","year":"1998","unstructured":"Kansy, M., F. Senner, and K. Gubernator. 1998. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem.41:1007-1010.","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(98)00181-9","volume":"101","year":"1999","unstructured":"Kinch, L. N., J. R. Scott, B. Ullman, and M. A. Phillips. 1999. Cloning and kinetic characterization of the Trypanosoma cruzi S-adenosylmethionine decarboxylase. Mol. Biochem. Parasitol.101:1-11.","journal-title":"Mol. Biochem. Parasitol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/S0021-9258(18)50153-8","volume":"237","year":"1962","unstructured":"Kitz, R., and I. B. Wilson. 1962. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J. Biol. Chem.237:3245-3249.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1021\/jm0201621","volume":"45","year":"2002","unstructured":"Marasco, C. J., Jr., D. L. Kramer, J. Miller, C. W. Porter, C. J. Bacchi, D. Rattendi, L. Kucera, N. Iyer, R. Bernacki, P. Pera, and J. R. Sufrin. 2002. Synthesis and evaluation of analogues of 5\u2032-([(Z)-4-amino-2-butenyl]methylamino)-5\u2032-deoxyadenosine as inhibitors of tumor cell growth, trypanosomal growth, and HIV-1 infectivity. J. Med. Chem.45:5112-5122.","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1645\/GE-633R.1","volume":"92","year":"2006","unstructured":"Nishimura, K., T. Yanase, N. Araki, Y. Ohnishi, S. Kozaki, K. Shima, M. Asakura, W. Samosomsuk, and S. Yamasaki. 2006. Effects of polyamines on two strains of Trypanosoma brucei in infected rats and in vitro culture. J. Parasitol.92:211-217.","journal-title":"J. Parasitol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3565(24)36999-X","volume":"283","year":"1997","unstructured":"Obach, R. S., J. G. Baxter, T. E. Liston, B. M. Silber, B. C. Jones, F. MacIntyre, D. J. Rance, and P. Wastall. 1997. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J. Pharmacol. Exp. Ther.283:46-58.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(97)00079-X"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1471-4159.2008.05706.x","volume":"107","year":"2008","unstructured":"Sanderson, L., M. Dogruel, J. Rodgers, B. Bradley, and S. A. Thomas. 2008. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain. J. Neurochem.107:1136-1146.","journal-title":"J. Neurochem."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0090-9556(24)13672-0","volume":"28","year":"2000","unstructured":"Stresser, D. M., A. P. Blanchard, S. D. Turner, J. C. Erve, A. A. Dandeneau, V. P. Miller, and C. L. Crespi. 2000. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab. Dispos.28:1440-1448.","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2008.07.006"},{"key":"e_1_3_2_32_2","unstructured":"W. H. O. 2008 posting date. Human African trypanosomiasis. World Health Organization Geneva Switzerland. http:\/\/www.who.int\/trypanosomiasis_african\/disease\/en\/index.html ."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0701111104"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000183"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01674-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01674-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:49:51Z","timestamp":1739018991000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01674-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1128\/AAC.01674-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.01674-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"2008-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}